Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Procyrion Inc. is currently managing 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 2 distinct art units, suggesting a portfolio that spans multiple specialized examination groups within the patent office. This diversity in art units requires a prosecution strategy that accounts for different internal guidelines and technical standards.
The prosecution workload is handled by 3 distinct examiners, showing that each pending action is currently under the review of a different individual. This distribution means the company must navigate the specific requirements and tendencies of the different examiners simultaneously. There is no concentration of work with a single individual, as the number of examiners matches the number of pending actions.
Among these individuals, LEE, ERICA SHENGKAI is identified as the busiest examiner for the portfolio. This examiner is responsible for 1 pending office action. Because the busiest examiner handles only a portion of the total pending workload, the portfolio's prosecution risk is spread across the examining corps. This structure prevents any 1 examiner's backlog from significantly delaying the entire portfolio's progress.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, ERICA SHENGKAI | 1 | 65.4% | +30.1% |
| GEDEON, BRIAN T | 1 | 86.9% | +7.2% |
| MORALES, JON ERIC C | 1 | 85.4% | +10.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18520086 | BLOOD PUMPS | MORALES, JON ERIC C | 74d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18525169 | INTRAVASCULAR BLOOD PUMP | GEDEON, BRIAN T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18751030 | SUPPORT STRUCTURES FOR INTRAVASCULAR BLOOD PUMPS | LEE, ERICA SHENGKAI | 84d overdue |
| 18520086 | BLOOD PUMPS | MORALES, JON ERIC C | 74d overdue |
| Art Unit | Apps |
|---|---|
| 3700 | 1 |
| 3796 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18751030 | SUPPORT STRUCTURES FOR INTRAVASCULAR BLOOD PUMPS | LEE, ERICA SHENGKAI | 3700 | §103 | Final Rejection | 84d overdue | Pending | Jun 21, 2024 |
| 18525169 | INTRAVASCULAR BLOOD PUMP | GEDEON, BRIAN T | — | §102§103 | Non-Final OA | — | Pending | Nov 30, 2023 |
| 18520086 | BLOOD PUMPS | MORALES, JON ERIC C | 3796 | §102DP | Final Rejection | 74d overdue | Pending | Nov 27, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial